STOCK TITAN

Bayview Acquisition: Nasdaq to proceed with delisting

The Nasdaq action concerns Bayview’s units, ordinary shares and rights, listed under symbols BAYAU, BAYA and BAYAR.

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(High)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
8-K

Rhea-AI Filing Summary

Bayview Acquisition Corp. reported that Nasdaq’s board declined to review earlier decisions setting a June 19, 2026 deadline to complete its business combination with Oabay Inc. and providing for suspension of trading afterward. Nasdaq said it would proceed with removing the company’s securities from listing. The company anticipated a Form 25-NSE filing to remove the securities from listing and registration; Nasdaq had not filed that form at the time of the report.

The company’s market maker filed Form 211 with FINRA on September 16, 2026, to initiate public quotation of the ordinary shares on the OTC Pink Market.

0 points · 0 major

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

1 major · 1 point

Hollow bars mark forward-looking points. How the balance works

Positive

  • None.

Negative

  • Major point. Forward-looking: it has not happened yet and may not happen.October 30: Nasdaq will proceed with removing Bayview’s securities from listing.
Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Securities
The company received a delisting notice, failed to satisfy a continued-listing rule or standard, or transferred its listing.
Nasdaq notice date October 30, 2026 Nasdaq said it would proceed with removing the company’s securities from listing.
Business-combination deadline June 19, 2026 Deadline set for completing the business combination with Oabay Inc.
Form 211 filing date September 16, 2026 The company’s market maker filed the form to initiate public quotation on the OTC Pink Market.
Form 25-NSE regulatory
"Nasdaq will file a Form 25-NSE with the SEC"
Form 25‑NSE is an official filing used to notify the stock exchange that a company’s securities are being removed from trading on that exchange, similar to handing in a key when a shop closes. Investors care because removal ends public trading on that venue, often cutting liquidity and making it harder to buy or sell shares, which can affect a stock’s price and how quickly investors can access cash or exit positions.
Form 211 regulatory
"filed a Form 211 with The Financial Industry Regulatory Authority (FINRA)"
Form 211 is the filing a broker-dealer submits to FINRA that provides the background, financial, and disclosure materials required under SEC Rule 15c2-11 before the dealer may publish or resume public quotations for a thinly traded or over-the-counter (OTC) security. It acts like an application that lets market makers show a bid and ask for a stock, so its acceptance affects whether and when a security becomes quoteable and thus how easily investors can buy or sell it.
OTC Pink Market market
"public quotation for the Company’s Ordinary Shares on the OTC Pink Market"
The OTC Pink Market is a segment of over-the-counter trading where shares of companies that do not meet formal exchange listing rules are bought and sold. It matters to investors because these stocks usually have little public information, low trading volume, and higher risk of price swings or fraud — like buying a rare item at a flea market where seller disclosure and return rules are minimal, so potential reward comes with greater uncertainty.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What is happening to BAYA’s Nasdaq listing?

Nasdaq said it would proceed with removing Bayview Acquisition Corp.’s securities from listing after its board declined to review earlier decisions. The company anticipated a Form 25-NSE filing to remove the securities from listing and registration.

Is BAYA seeking an OTC Pink quotation?

Yes. The company said its market maker filed Form 211 with FINRA on September 16, 2026, to initiate public quotation of its ordinary shares on the OTC Pink Market.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
false 0001969475 0001969475 2026-10-30 2026-10-30 0001969475 BAYAU:UnitsEachConsistingOfOneOrdinaryShareAndOneRightMember 2026-10-30 2026-10-30 0001969475 BAYAU:OrdinarySharesParValue0.0001PerShareMember 2026-10-30 2026-10-30 0001969475 BAYAU:RightsEachRightEntitlingHolderThereofToOnetenthOfOneOrdinaryShareMember 2026-10-30 2026-10-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

current report

pursuant to section 13 or 15(D)

of the securities exchange act of 1934

 

Date of Report (Date of earliest event reported): October 30, 2026

 

Bayview Acquisition Corp

(Exact name of registrant as specified in its charter)

 

Cayman Islands   001-41890   N/A

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification Number)

 

420 Lexington Ave, Suite 2446

New York, NY 10170

(Address of principal executive offices, including zip code)

 

Registrant’s telephone number, including area code (347) 627-0058

 

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered 
Units, each consisting of one ordinary share and one right   BAYAU   The Nasdaq Stock Market LLC
Ordinary Shares, par value $0.0001 per share   BAYA   The Nasdaq Stock Market LLC
Rights, each right entitling the holder thereof to one-tenth of one ordinary share   BAYAR   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act ☐

 

 

 

 

 

 

Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

 

As previously disclosed, on September 22, 2026, Bayview Acquisition Corp., a Cayman Islands exempted company (the “Company”) received two written notices from the Listing and Hearing Review Council (the “Council”) of Nasdaq stating that the Council had affirmed the Hearings Panel (the “Panel”) of Nasdaq’s previous decisions to (a) set the June 19, 2026 deadline for the Company to complete its business combination with Oabay Inc., a Cayman Islands exempted company limited by shares, and (b) thereafter, suspend the trading of the Company’s securities.

 

On October 30, 2026, the Company received a written notice from Nasdaq stating that Nasdaq’s board of directors declined to call the above-mentioned decisions for review and that Nasdaq would proceed with removing the Company’s securities from listing. The Company anticipates that Nasdaq will file a Form 25-NSE with the SEC, which will remove the Company’s securities from listing and registration on Nasdaq. As of the date of this Current Report on Form 8-K, Nasdaq has not filed a Form 25-NSE.

 

As previously disclosed, the Company is seeking quotation on the OTC Markets. On September 16, 2026, the Company’s market maker filed a Form 211 with The Financial Industry Regulatory Authority (FINRA), to initiate a public quotation for the Company’s Ordinary Shares on the OTC Pink Market.

 

Forward-Looking Statements

 

This Current Report on Form 8-K may include “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Certain of these forward-looking statements can be identified by the use of words such as “believes,” “expects,” “intends,” “plans,” “estimates,” “assumes,” “may,” “should,” “will,” “seeks,” or other similar expressions. Such statements are subject to certain risks and uncertainties that may cause the Company’s actual results to differ from the expectations expressed in the forward-looking statements. There can be no assurance that the Company will achieve such expectations. The forward-looking statements contained in this report speak only as of the date of this report and the Company undertakes no obligation to publicly update any forward-looking statements to reflect changes in information, events or circumstances after the date of this report, unless required by law.

 

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: November 4, 2026 Bayview Acquisition Corp
   
  By: /s/ Xin Wang
  Name: Xin Wang
  Title: Chief Executive Officer and Director

 

 

 

Filing Exhibits & Attachments

4 documents

Keep reading